Basilea Pharmaceutica Ltd. Logo

Mr. Ronald Scott

Scott R   Ronald Scott, Swiss citizen, was elected as a member of the Board of Directors in April 2018.  He served as Basilea's Chief Executive Officer from January 2013 until April 2018. He was Basilea's Chief Operating Officer from January 2012 through December 2012, and served as Chief Financial Officer from the Company’s founding in 2000 through January 2012 as well as ad interim Chief Financial Officer from February 2013 until November 2013. From 2004 to October 2011, Mr. Scott served on the Board of Directors and was a co-founding Board member in 2000. Prior to joining Basilea, Mr. Scott worked at Roche Holding AG (Roche) in management positions in Pharmaceutical Finance, Licensing, and the Roche Corporate Finance Mergers and Acquisitions group. Prior to joining Roche, Mr. Scott worked for Prudential Investment Corporation in the United States as Director in Prudential’s Finance and International Business Development Units, managing divestitures and joint venture transactions. In May 2017, Mr. Scott was elected as a member of the supervisory board of Medigene AG (Germany) and since July 2018 is serving as a member of the board of the privately held company, KIDpharma AG (Switzerland). Mr. Scott has a bachelor’s degree from Utah State University (USA) and a master’s degree from Harvard University (USA).